112 related articles for article (PubMed ID: 2112282)
1. Cyclosporine monitoring in liver allograft recipients: two distinct patterns of blood level derangement associated with nephrotoxicity.
Wonigeit K; Kohlhaw K; Winkler M; Schaefer O; Pichlmayr R
Transplant Proc; 1990 Jun; 22(3):1305-11. PubMed ID: 2112282
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
[No Abstract] [Full Text] [Related]
3. A prospective study of cyclosporine monitoring in renal transplantation.
Lindholm A
Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
[No Abstract] [Full Text] [Related]
4. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
Stiller C; Keown P
Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
[No Abstract] [Full Text] [Related]
5. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
Häyry P; von Willebrand E; Ahonen J
Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
Sridhar N; Schroeder TJ; Pesce AJ; First MR
Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
[No Abstract] [Full Text] [Related]
7. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
[No Abstract] [Full Text] [Related]
8. Bile refeeding after liver transplantation and avoidance of intravenous cyclosporine.
Merion RM; Gorski DH; Burtch GD; Turcotte JG; Colletti LM; Campbell DA
Surgery; 1989 Oct; 106(4):604-9; discussion 609-10. PubMed ID: 2799635
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
[TBL] [Abstract][Full Text] [Related]
10. Biologic activity of cyclosporine metabolites.
Sewing KF; Christians U; Kohlhaw K; Radeke H; Strohmeyer S; Kownatzki R; Budniak J; Schottmann R; Bleck JS; Almeida VM
Transplant Proc; 1990 Jun; 22(3):1129-34. PubMed ID: 2349673
[No Abstract] [Full Text] [Related]
11. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
[No Abstract] [Full Text] [Related]
12. Factors predictive of cyclosporine-induced nephrotoxicity: the role of cyclosporine blood levels.
Bach JF; Feutren G; Noel LH; Hannedouche T; Landais P; Timsit J; Boitard C; Bougnères P; Boitard C; Grünfeld JP
Transplant Proc; 1990 Jun; 22(3):1296-8. PubMed ID: 2349690
[No Abstract] [Full Text] [Related]
13. [Clinical relevance of N-acetylglucosaminidase determination in urine of kidney transplant recipients with and without cyclosporin A].
Loertscher R; Scholer A; Brunner F; Harder F; Thiel G
Schweiz Med Wochenschr; 1982 Nov; 112(46):1658-64. PubMed ID: 6760389
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
15. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
[TBL] [Abstract][Full Text] [Related]
16. Influence of different parameters for the monitoring of cyclosporine.
Humbert H; Vernillet L; Cabiac MD; Barradas J; Billaud E
Transplant Proc; 1990 Jun; 22(3):1210-5. PubMed ID: 2349682
[No Abstract] [Full Text] [Related]
17. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
[No Abstract] [Full Text] [Related]
18. Cyclosporine A nephrotoxicity in liver graft recipients: determination of nephrotoxic cyclosporine blood concentrations in liver graft recipients as defined by the HPLC and RIA tests.
Hamilton G; Mühlbacher F; Roth E; Steininger R; Wolf I; Schindler J; Wolosczuk W; Piza F
Transplant Proc; 1987 Oct; 19(5):4045-8. PubMed ID: 3313996
[No Abstract] [Full Text] [Related]
19. Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function.
Emre S; Gondolesi G; Polat K; Ben-Haim M; Artis T; Fishbein TM; Sheiner PA; Kim-Schluger L; Schwartz ME; Miller CM
Liver Transpl; 2001 Mar; 7(3):220-5. PubMed ID: 11244163
[TBL] [Abstract][Full Text] [Related]
20. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
